Aimee Hechanova
1 , Pouria Mostafizi
2 , Kiyan Rad
3 , Ramin Tolouian
4* 1 Division of Nephrology, Paul L. Foster School of Medicine, Texas Tech University Health Science Center of El Paso, El Paso, Texas, USA
2 Department of Physiology, College of Medicine, University of Arizona, Tucson, Arizona, USA
3 Department of Internal Medicine, Southern Arizona VA Health Care System and College of Medicine, University of Arizona, Tucson, Arizona, USA
4 Division of Nephrology, Southern Arizona VA Health Care System and College of Medicine, University of Arizona, Tucson, Arizona, USA
Implication for health policy/practice/research/medical education:
It has been demonstrated that iron deposition in the kidney is a harbinger of poor prognosis, but it is not clear whether kidney failure/damage predisposes iron deposition, or iron deposition activates an oxidative cascade and causes kidney damage. Until this issue is clarified, it will be difficult to predict the risks or benefits of any iron infusion for chronic kidney disease.
Please cite this paper as: Hechanova A, Mostafizi P, Rad K, Tolouian R. The ferric conundrum: which intravenous iron preparations are preferred for chronic kidney disease patients? J Nephropathol. 2022;11(3):e17372. DOI: 10.34172/jnp.2022.17372.